SOUTH PORTLAND, Maine, [March 19, 2024] — ElleVet Sciences, the first company to prove the safety and efficacy of its hemp-based CBD products for pets, announces the recent expansion of its executive leadership team with the promotion of Haley Israelson to Chief Financial Officer, and addition of Ryan Shadrin as Chief Commercial Officer.
Israelson, who previously served as VP of Finance, Operations & Ecommerce, assumed the role of Chief Financial Officer in January and now leads the company’s accounting, finance, and treasury functions. Prior to joining ElleVet, Israelson served as a finance and investment professional in the venture capital and private equity space, where she worked with numerous high growth startups. Haley is a Certified Public Accountant in the State of Maine who earned her MBA and BS in Accounting from Husson University.
“I’m proud to be part of a rapidly growing company that is revolutionizing the animal health industry by developing safe, effective solutions to common issues that pets face. Our commitment to making a lasting impact on pets’ lives is at the core of our mission,” Israelson explained. “My journey with ElleVet has been one of personal and professional growth, and I’m excited to continue driving innovation and creating significant value with the ElleVet team.”
Shadrin joins ElleVet as Chief Commercial Officer leading the company’s ecommerce, marketing, customer experience, and sales teams. With over 25 years of marketing and operator experience, Shadrin has held the roles of Chief Marketing Officer, Chief Revenue Officer, and Global VP of Direct to Consumer for companies ranging from start-ups to multi-billion dollar, publicly traded corporations. Ryan holds a BA in History from Hamilton College and certification in AI and Machine Learning from Stanford School of Engineering.
“Just as ElleVet has applied scientific rigor to the development of the most vet recommended CBD + CBDA pet health supplements, I aim to apply data science and analytics to build market share, personalize the customer journey, and maximize revenue opportunities,” Shadrin shared. “This synthesis of science and strategy will drive our mission forward, ensuring that every decision enhances our ability to make a real difference in the lives of pets and their families.”
The expansion of the ElleVet leadership team is a key milestone in the company’s strategic growth plan.
“We are excited to announce the promotion of Haley and the hiring of Ryan as we continue to grow ElleVet Sciences and explore the role of cannabinoids in animal health,” said Christian Kjaer, CEO and Co Founder of ElleVet Sciences. “Haley and Ryan will play integral roles in ElleVet’s leadership and future. Their unique and impressive expertise, passion, and energy will have a strong impact on ElleVet’s strategic goals and future growth.”
About ElleVet Sciences
ElleVet Sciences is a leading science-focused pet CBD + CBDA company based in Portland, Maine, USA. As the first and only organization to conduct successful CBD + CBDA clinical trials, ElleVet has pioneered the use of complete spectrum cannabinoid oil to support mobility, stress, skin, neuro, and cognitive health in pets. ElleVet’s team includes the very same veterinary professionals who brought CBD + CBDA veterinary science to the forefront of pet health research. ElleVet was founded in 2017, the same year
their landmark clinical trial on osteoarthritis was completed at Cornell University College of Veterinary Medicine. With more than 40 clinical trials and R&D projects completed or underway, ElleVet Sciences is committed to improving the lives of pets through science and innovation.
For more information, please visit ellevetsciences.com or on social media at @Ellevetsciences on Facebook and Instagram.
